MedTrace Logo

NYU/Bellevue WTC Health Impacts Research Registry

NCT00404898 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40000

Last updated 2025-07-02

No results posted yet for this study

Summary

The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial spaces, and c) responders to the WTC collapse. These populations are recruited from past and ongoing programs that we have developed as well as from ongoing collaborations with community organizations that include: the Beyond Ground Zero Network, 9/11 Environmental Action committee, and the WTC Residents Coalition. In addition, there is collaboration with the Charles B. Wang Community Health Center and the centers involved in the ongoing WTC Workers and Volunteer Medical Screening and Monitoring Program. We would now like to access the data from this treatment program to create a NYU/Bellevue WTC Health Impacts Research Registry to increase knowledge about the health effects of exposure to World Trade Center dust.

Conditions

  • Exposure to World Trade Center Dust

Sponsors & Collaborators

  • National Institute for Occupational Safety and Health (NIOSH/CDC)

    collaborator FED

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Joan Reibman, MD · NYU Langone Health

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00404898 on ClinicalTrials.gov